Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schulte, Johannes H" or (type exact bookEditor and editor="Schulte, Johannes H")

Add to list
- Conference Paper
- C3
Reduced DICER1 functionality in neuroblastoma through reduced expression levels or somatic mutations

Bram De Wilde (UGent) , Johannes H Schulte, Anneleen Beckers (UGent) , Alexander Schramm, Annelies Fieuw (UGent) , Daniel Carter, Belamy Cheung, Glenn Marshall, Angelika Eggert, Katleen De Preter (UGent) , et al.

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Ana Berbegall, Rosa Noguera, Jayne Murray, Michele Haber, Raymond L Stallings, Johannes H Schulte, Valérie Combaret, Gudrun Schleiermacher, et al.

(2014) ANR Cologne 2014 : information book.
Add to list
- Journal Article
- A1
- open access
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling

Sangkyun Lee, Jörg Rahnenführer, Michel Lang, Katleen De Preter (UGent) , Pieter Mestdagh (UGent) , Jan Koster, Rogier Versteeg, Raymond L Stallings, Luigi Varesio, Shahab Asgharzadeh, et al.

(2014) PLOS ONE. 9(10).
Add to list
- Journal Article
- A1
- open access
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjorabla Zeka, Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes H Schulte, et al.

(2014) PLOS ONE. 9(12).
Add to list
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

Ali Rihani (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Koen Norga, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, et al.

(2014) PEDIATRIC BLOOD & CANCER. 61(10). p.1867-1870
Add to list
Early targets of miR-34a in neuroblastoma

Pasqualino De Antonellis, Marianeve Carotenuto, Jonathan Vandenbussche (UGent) , Gennaro De Vita, Veronica Ferrucci, Chiara Medaglia, Iolanda Boffa, Alessandra Galiero, Sarah Di Somma, Daniela Magliulo, et al.

(2014) MOLECULAR & CELLULAR PROTEOMICS. 13(8). p.2114-2131
Add to list
- Conference Paper
- C3
Genome wide expression, mutation and methylation analysis validates three new mouse models for neuroblastoma targeting MYCN, ALK and LIN28B for pre-clinical studies

Anneleen Beckers (UGent) , Bram De Wilde (UGent) , Maté Ongenaert (UGent) , Candy Kumps (UGent) , Johannes H Schulte, Jo Vandesompele (UGent) , Katleen De Preter (UGent) and Franki Speleman (UGent)

(2013) Belgian Society of Human Genetics, 13th Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
The MYCN driven murine and human neuroblastoma methylome and dynamic regulation of chromatin regulators as a guide for epigenetic therapy

Anneleen Beckers (UGent) , Anneleen Decock (UGent) , Belamy Cheung, Daniel Carter, Gert Van Peer (UGent) , Sara De Brouwer (UGent) , Genevieve Laureys (UGent) , Jo Vandesompele (UGent) , Johannes H Schulte, Glenn Marshall, et al.

(2013) Cancer Epigenomics, Cell symposia, Abstracts.
Add to list
- Journal Article
- A1
- open access
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma

Anton Henssen, Theresa Thor, Andrea Odersky, Lukas Heukamp, Nicolai El-Hindy, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Kristina Althof, Simon Schäfers, Alexander Schramm, et al.

(2013) ONCOTARGET. 4(11).
Add to list
- Conference Paper
- C3
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2013) Cancer Epigenomics, Cell symposia, Abstracts.

← Previous

Academic Bibliography

Reduced DICER1 functionality in neuroblastoma through reduced expression levels or somatic mutations

Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups

Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

Early targets of miR-34a in neuroblastoma

Genome wide expression, mutation and methylation analysis validates three new mouse models for neuroblastoma targeting MYCN, ALK and LIN28B for pre-clinical studies

The MYCN driven murine and human neuroblastoma methylome and dynamic regulation of chromatin regulators as a guide for epigenetic therapy

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Contents

Support

Contact